Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jelle Barentsz

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|April 25, 2003
Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRIWilliam Leenders, Benno Küsters, Jeroen Pikkemaat, et al.
BJU International|January 20, 2012
Novel approaches to improve prostate cancer diagnosis and management in early-stage diseaseMichael Marberger, Jelle Barentsz, Mark Emberton, et al.
European Urology|September 20, 2011
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohortThomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al.
The New England Journal of Medicine|June 20, 2003
Noninvasive detection of clinically occult lymph-node metastases in prostate cancerMukesh G Harisinghani, Jelle Barentsz, Peter F Hahn, et al.
European Urology|November 20, 2021
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local AnesthesiaJos Immerzeel, Bas Israël, Joyce Bomers, et al.
European Radiology|May 23, 2024
ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESURAndrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo, et al.
Investigative Radiology|December 29, 2010
Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation studyTom W J Scheenen, Jurgen Fütterer, Elisabeth Weiland, et al.
BJU International|August 6, 2021
Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancerBas Israël, Jos Immerzeel, Marloes van der Leest, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Radiology|June 12, 2019
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy PathwayAnwar R Padhani, Jelle Barentsz, Geert Villeirs, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|April 25, 2003
Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRIWilliam Leenders, Benno Küsters, Jeroen Pikkemaat, et al.
BJU International|January 20, 2012
Novel approaches to improve prostate cancer diagnosis and management in early-stage diseaseMichael Marberger, Jelle Barentsz, Mark Emberton, et al.
European Urology|September 20, 2011
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohortThomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al.
The New England Journal of Medicine|June 20, 2003
Noninvasive detection of clinically occult lymph-node metastases in prostate cancerMukesh G Harisinghani, Jelle Barentsz, Peter F Hahn, et al.
European Urology|November 20, 2021
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local AnesthesiaJos Immerzeel, Bas Israël, Joyce Bomers, et al.
European Radiology|May 23, 2024
ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESURAndrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo, et al.
Investigative Radiology|December 29, 2010
Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation studyTom W J Scheenen, Jurgen Fütterer, Elisabeth Weiland, et al.
BJU International|August 6, 2021
Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancerBas Israël, Jos Immerzeel, Marloes van der Leest, et al.
European Radiology|May 15, 2021
ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imagingTobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Radiology|June 12, 2019
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy PathwayAnwar R Padhani, Jelle Barentsz, Geert Villeirs, et al.
Pageof 4